Grants and Contributions:
Title:
Development and validation of a subcutaneous delivery formulation of a bone-healing therapeutic
Agreement Number:
985072
Agreement Value:
$413,500.00
Agreement Date:
Dec 6, 2021 - Mar 31, 2023
Description:
This project will help the firm develop, optimize and characterize a formulation of their lead therapeutic compound that is suitable for administration via subcutaneous injection. Efficacy of the new formulation will also be functionally validated.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2021-2022-Q4-985072
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
832032031
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days. The total amended value is 100,000 dollars.
Amendment Date
Jan 9, 2023
Recipient's Legal Name:
Mesentech Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: